XML 85 R74.htm IDEA: XBRL DOCUMENT v3.23.1
Net Loss Per Share - Narrative (Details) - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jan. 19, 2023
Dec. 31, 2022
Feb. 11, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Options outstanding (in shares) 4,936,049 893,986   2,982,893  
Weighted-average exercise price average exercise price (in usd per share) $ 2.39     $ 2.89  
Exercise price (in usd per shares) $ 11.50 $ 11.50      
Debt conversion, converted instrument, shares issued (in shares) 18,844,600 17,931,304      
Debt instrument, convertible, conversion price (in usd per share) $ 10.61 $ 11.50      
Maximum number of shares per employee (in shares) 2,667,501        
Options, exercise price (in usd per share) $ 6.43 $ 8.57      
Restricted Stock Units (RSUs)          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Shares outstanding (in shares) 12,882,588 3,148,274      
Performance Shares          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Shares outstanding (in shares) 1,308,026 150,000      
Private warrants          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Number of securities called by warrant (in shares) 174,894 366,533      
Exercise price (in usd per shares) $ 11.50     $ 11.50  
Public Warrants          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Number of securities called by warrant (in shares) 12,150,878 11,959,939     1
Exercise price (in usd per shares)         $ 11.50
PIPE warrants          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Number of securities called by warrant (in shares) 13,888,889        
Exercise price (in usd per shares) $ 2.39   $ 2.39